Arsenal’s squad depth has been praised since the start of this season, and the club might have found itself in a far more difficult position had it not increased its numbers across the pitch. The ...

RAS Technology Holdings Limited ( (AU:RTH)) just unveiled an update. RAS Technology Holdings Limited has announced the issuance of 1,086,872 fully paid ordinary shares. This move, made without ...

In both cases, we observe the construction of an identity consolidated over decades — or even centuries — supported by a set of factors that inscribe them into history. Not only because of the ...

China has suspended export controls announced this month, but was conspicuously silent about rules imposed earlier, which are snarling global supply chains. By Keith Bradsher Reporting from Beijing ...

SHENZHEN, CHINA - APRIL 12: A Chinese national flag is seen in the foreground with container ships, cranes, and stacked shipping containers at the Yantian International Container Terminal under cloudy ...

Have you ever had a conversation with someone who came off as ridiculously shallow? They’re often judgmental and self-absorbed. It can be hard to discuss anything important with them, as they are more ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

LATROBE, Pa. – The Steelers open their preseason with a 7 p.m. game on Saturday, Aug. 9 against the Jaguars in Jacksonville, which means the release of the first depth chart of the 2025 season. And ...

Section 1. Purpose. Artificial intelligence (AI) is a foundational technology that will define the future of economic growth, national security, and global competitiveness for decades to come. The ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.